交易中 05-11 12:11:42 美东时间
-0.825
-2.08%
BTIG analyst David Larsen reiterates Medline (NASDAQ:MDLN) with a Buy and maintains $55 price target.
05-07 18:04
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219163
04-24 22:13
Medline (NASDAQ:MDLN) announced a strategic agreement to implement next-generation warehouse automation from Symbotic, a leader in AI-enabled robotics technology, as part of the company's ongoing efforts to strengthen
04-17 03:45
FDA warns Medline over device quality lapses, citing CAPA failures, contamination risks, and unresolved syringe disconnection issues.
04-10 02:02
Blackstone, The Carlyle Group, Hellman and Friedman LLC, and the ADIA, are offering 75 million shares for Medline's class A common stock.
03-04 01:27
Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi
03-03 20:08
In the current market session, Medline Inc. (NASDAQ:MDLN) stock price is at $49...
02-24 01:00
FDA labels Medline homecare bed instruction update as most serious recall after reports of fires, injuries and deaths linked to electrical risks.
02-14 02:11
Medline received favorable coverage from several analysts. It recently raised $7 billion in an IPO and has a strong product portfolio.
01-13 02:59
Medtronic's (NYSE: MDT) diabetes unit, MiniMed Group, filed for a U.S. initial public offering (IPO) on Friday.
2025-12-20 10:26